Multiple myeloma with CD138 changed from positive to negative: A case report

被引:1
作者
Yu, Jianlin [1 ]
Tan, Liming [1 ]
Wu, Qiong [1 ]
Rao, Yanfei [1 ]
Ao, Jianyun [1 ]
Yang, Weiming [1 ]
Zou, Bei [1 ]
Chen, Juanjuan [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Clin Lab, Jiangxi Prov Key Lab,Lab Med, Nanchang 330006, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
CD138; flow cytometry; multiple myeloma; CELLS; SURVIVAL;
D O I
10.1002/cyto.b.21869
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background Multiple myeloma (MM) is a common malignant disease of the blood system, caused by the neoplastic proliferation of plasma cells that accumulate in bone marrow (BM). Here, we report a case of MM patient with CD138 marker changed from positive to negative. Methods BM and peripheral blood samples from a 48-year-old patient with MM were examined and analyzed by conventional morphology, flow cytometry, and immunodetection. Results Imaging examination and clinical manifestations fulfilled criteria for MM. On the first hospitalization, flow cytometry showed that the cells were CD138(+)/CD38(+)/CD19(-)/CD56(+). However, on the fifth hospitalization, flow cytometry revealed that the cells were CD138(-)/CD38(+)/CD19(-)/CD56(+). Conclusions MM is diagnosed on imaging and clinical manifestations, immunophenotype of flow cytometry is also an important method of diagnosing MM. However, the discovery of atypical immunophenotypes cannot prevent the diagnosis of MM, even provide a clue of disease progression.
引用
收藏
页码:249 / 253
页数:5
相关论文
共 50 条
  • [42] CD38: From Positive to Negative Expression After Daratumumab Treatment. Case Report
    Patino, Bonell
    Martinez, Humberto
    Enciso, Leonardo
    Otero, Diana
    Spirko, Paola
    Arevalo, Monica
    Roa, Carmen
    Chinchilla, Sandra
    Naranjo, Andrea
    Bedon, Giovanna
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S243 - S243
  • [44] Patients with CD45 negative multiple myeloma receiving high-dose therapy have it shorter survival than those with CD45 positive multiple myeloma
    Moreau, P
    Robillard, N
    Avet-Loiseau, H
    Pineau, D
    Morineau, N
    Milpied, N
    Harousseau, JL
    Bataille, R
    HAEMATOLOGICA, 2004, 89 (05) : 547 - 551
  • [45] Peroxidase-positive Auer bodies in plasma cells in multiple myeloma: a case report
    Zhu, Lin
    An, Li
    Zhang, Xiao-Yan
    Ren, Xue-Rui
    Song, Jing-Wen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 15301 - 15306
  • [46] Compartmental Syndecan-1 (CD138) expression as a novel prognostic marker in triple-negative metaplastic breast cancer
    Ismail, Yahia
    Zakaria, Al-Shimaa
    Allam, Rasha
    Goette, Martin
    Ibrahim, Sherif Abdelaziz
    Hassan, Hebatallah
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 253
  • [47] Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by SynstatinIGF1R Inhibits Tumor Growth
    Beauvais, DeannaLee M.
    Jung, Oisun
    Yang, Yang
    Sanderson, Ralph D.
    Rapraeger, Alan C.
    CANCER RESEARCH, 2016, 76 (17) : 4981 - 4993
  • [48] Pleural effusion and multiple myeloma-more than meets the eye: A case report
    Ramos, Ana Luisa
    Trindade, Miguel
    Santos Pinto, Andre
    Brandao, Jose Ricardo
    Pedrosa, Claudia
    Pinto, Alexandre
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 15 (05)
  • [49] Multiple myeloma with monoclonal surface immunoglobulin expression - A case report
    Dunphy, CH
    Galindo, LM
    Velasquez, WS
    ACTA CYTOLOGICA, 1996, 40 (02) : 358 - 362
  • [50] Immunohistological diagnosis of plasma cell myeloma based on cytoplasmic kappa/lambda ratio of CD138-positive plasma cells
    Nakayama-Ichiyama, Shoko
    Yokote, Taiji
    Hirata, Yuji
    Iwaki, Kazuki
    Akioka, Toshikazu
    Miyoshi, Takuji
    Takayama, Ayami
    Nishiwaki, Uta
    Masuda, Yuki
    Nishimura, Yasuichiro
    Tsuji, Motomu
    Hanafusa, Toshiaki
    LEUKEMIA & LYMPHOMA, 2012, 53 (11) : 2205 - 2209